Cannabis use and lung cancer: time to stop overlooking the problem?
Léa Betser, Matthieu Glorion, Pierre Mordant, Caroline Caramella, Maria-Rosa Ghigna, Benjamin Besse, David Planchard, Jérome Le Pavec, Alain Chapelier, Sylvie Friard, Valérie Gounant, Yves Castier, Antonin Levy, Olaf Mercier, Dominique Fabre, Elie Fadel, Pauline Pradere
Source: Eur Respir J, 57 (5) 2004132; 10.1183/13993003.04132-2020
Abstract
After tobacco, cannabis is the most widely used drug worldwide, and the move to legalise it is growing in more and more countries. The literature about the involvement of cannabis smoking on the development of lung cancer is scarce and most often reassuring [1–3], even though the concentration of carcinogens in cannabis smoke is unquestionably greater than that in tobacco smoke [4]. Moreover, recent studies on cannabis tend to focus on possible therapeutic effects [5]. Studies of the carcinogenic impact of cannabis are indeed limited by its frequent association with tobacco smoking and by its illegal status in most countries [6].
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Léa Betser, Matthieu Glorion, Pierre Mordant, Caroline Caramella, Maria-Rosa Ghigna, Benjamin Besse, David Planchard, Jérome Le Pavec, Alain Chapelier, Sylvie Friard, Valérie Gounant, Yves Castier, Antonin Levy, Olaf Mercier, Dominique Fabre, Elie Fadel, Pauline Pradere. Cannabis use and lung cancer: time to stop overlooking the problem?. Eur Respir J, 57 (5) 2004132; 10.1183/13993003.04132-2020
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: